The group around Du XIANG at Fudan University Cancer Hospital is using the anaplastic lymphoma kinase (ALK) gene as a marker for the early identification of NSLC which support appropriate therapy.
China Bio news release, June 16, 2015
The group around Du XIANG at Fudan University Cancer Hospital is using the anaplastic lymphoma kinase (ALK) gene as a marker for the early identification of NSLC which support appropriate therapy.
China Bio news release, June 16, 2015
This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year. Accept or Deny